Renal Function Outcomes in Tuberous Sclerosis Complex Patients Receiving Everolimus for Renal Angiomyolipoma
In this study, we evaluated kidney function in patients with renal angiomyolipoma associated with tuberous sclerosis complex (TSC-RAML), who received everolimus treatment. We found that kidney function was generally stable and even improved in patients with marked tumor reduction. These results suggest that everolimus may help preserve or enhance kidney health in selected patients with TSC-RAML.
Authors
- Yushi Zhang
- Dongxu Qiu
- Yang Zhao
- Zhangcheng Liao
- Wenda Wang
- Yi Liu (ORCID: https://orcid.org/0009-0007-6962-5745)
Institutions
- Central South University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1016/j.euros.2025.12.013
- Primary Topic
- Tuberous Sclerosis Complex Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00